Quarterly report pursuant to Section 13 or 15(d)

Mortgage Note Payable and Line of Credit

v2.4.0.8
Mortgage Note Payable and Line of Credit
6 Months Ended
Jun. 30, 2013
Debt Disclosure [Abstract]  
Mortgage Note Payable and Line of Credit

NOTE 5. MORTGAGE NOTE PAYABLE AND LINE OF CREDIT

Our mortgage note payable and line of credit as of June 30, 2013, and December 31, 2012, are summarized below:

 

                               As of June 30, 2013      As of December 31, 2012  

Issuer

   Type of
Issuance
   Date of
Issuance
     Initial
Commitment
     Maturity
Date
     Principal
Outstanding
     Stated
Interest
Rate
    Remaining
Availability
     Principal
Outstanding
     Stated
Interest
Rate
    Remaining
Availability
 

MetLife

   Mortgage Note Payable      12/30/2010         45,200,000         1/5/2026       $ 29,489,165         3.50   $ 13,565,000       $ 30,717,880         3.50   $ 13,565,000   

MetLife

   Line of Credit      5/31/2012         4,785,000         4/5/2017         100,000         3.28     4,685,000         100,000         3.35     4,685,000   
           

 

 

    

 

 

      

 

 

    

 

 

      

 

 

 
              Totals:       $ 29,589,165         $ 18,250,000       $ 30,817,880         $ 18,250,000   
           

 

 

    

 

 

      

 

 

    

 

 

      

 

 

 

The weighted-average effective interest rate charged on all of our borrowings, excluding the impact of deferred financing costs, was 3.63% and 3.62% for the three and six months ended June 30, 2013, respectively, as compared to 3.69% and 3.67% for the three and six months ended June 30, 2012, respectively.

Mortgage Note Payable

On December 30, 2010, we executed a loan agreement with Metropolitan Life Insurance Company (“MetLife”) in an amount not to exceed $45.2 million, pursuant to a long-term note payable. The note currently accrues interest at a rate of 3.50% per year, and the interest rate is subject to adjustment on January 5, 2014, and every three years thereafter to then-current market rates. The note is scheduled to mature on January 5, 2026, and we may not repay the note prior to maturity, except on one of the four interest rate adjustment dates. The loan originally provided for three disbursements, which were drawn in 2011, and was amended in December 2011 to provide for three additional disbursements, two of which were drawn prior to the December 2012 amendment. In connection with the December 2011 amendment, we also incur a commitment fee of 0.20% on undrawn amounts, effective January 5, 2012. As amended in December 2012, the loan agreement provides for up to three additional future disbursements by December 2013, none of which have been drawn to date.

As of June 30, 2013, $29.5 million was outstanding under this loan. The remaining three disbursements may not exceed $13.6 million, in aggregate, and must be used solely to fund acquisitions of new property. The interest rate for future disbursements will be based on prevailing market rates, and at the time of such disbursements, the interest rate on the loan will adjust to reflect the rate on the new disbursement blended with the existing rate on the then-outstanding loan amount. If we have not drawn such funds for the acquisition of new properties by December 14, 2013, MetLife has the option to be relieved of its obligation to disburse the additional funds to us under this loan.

 

The fair value of the mortgage note payable outstanding as of June 30, 2013, was $31.2 million, as compared to a carrying value of $29.5 million. The fair value of the mortgage note payable is valued using Level 3 inputs under the hierarchy established by ASC 820, “Fair Value Measurements and Disclosures,” and is calculated based on a discounted cash flow analysis, using interest rates based on management’s estimates of market interest rates on long-term debt with comparable terms.

Scheduled principal payments of the mortgage note payable for the remainder of 2013 and each of the five succeeding fiscal years and thereafter are as follows:

 

Period

   Scheduled
Principal
Payments
 

For the remaining six months ending December 31:

   2013    $ —     

For the fiscal years ending December 31:

   2014      1,179,567   
   2015      1,132,384   
   2016      1,087,088   
   2017      1,043,605   
   2018      1,001,861   
   Thereafter      24,044,660   
     

 

 

 
      $ 29,489,165   
     

 

 

 

All of the properties owned as of June 30, 2013, with the exception of San Andreas, 38th Avenue and Sequoia Street have been pledged as collateral under this mortgage note payable.

Line of Credit

In November 2002, we entered into a $3.3 million revolving line of credit facility with Rabo Agrifinance (the “Prior Credit Facility”), which was scheduled to mature on December 1, 2017, secured by San Andreas. In May 2012, we repaid the outstanding balance, in full, under the Prior Credit Facility and obtained a new, $4.8 million revolving line of credit with MetLife that matures on April 5, 2017 (the “Credit Facility”). Our obligations under the Credit Facility are secured by a mortgage on San Andreas. The interest rate charged on the advances under the Credit Facility is equal to the three-month LIBOR in effect at the beginning of each calendar quarter plus 3.00%, with a minimum annualized rate of 3.25%. We may use advances under the Credit Facility for both general corporate purposes and the acquisition of new properties.

As of both June 30, 2013, and December 31, 2012, there was $0.1 million outstanding under the Credit Facility, which is the minimum balance required, and approximately $4.7 million of availability from which we could draw. Due to the short-term and revolving nature of a line of credit, the carrying value of our Credit Facility of $0.1 million at both June 30, 2013, and December 31, 2012, is deemed to approximate fair value.